ISSN 1662-4009 (online)

ey0019.6-16 | Gender Incongruence: Wider impacts of gender affirming hormone (GAH) treatments | ESPEYB19

6.16. Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria

Blok CJ de , CM Wiepjes , Velzen DM van , AS Staphorsius , NM Nota , LJ Gooren , BP Kreukels , Heijer M den

Lancet Diabetes Endocrinol. 2021 Oct;9(10):663-670. PMID: 34481559, doi: 10.1016/S2213-8587(21)00185-6. Brief Summary: This paper reports standardised mortality rates (SMR) between 1972 and 2018 in a large cohort of 2927 transgender women and 1641 transgender men from the Amsterdam Cohort of Gender Dysphoria. It finds a higher SMR for transgender women compared with transgender men. </p...

ey0015.6-4 | Important for clinical practice | ESPEYB15

6.4 The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets

CM Wiepjes , NM Nota , CJM de Blok , M Klaver , ALC de Vries , SA Wensing-Kruger , RT de Jongh , MB Bouman , TD Steensma , P Cohen-Kettenis , LJG Gooren , BPC Kreukels , M den Heijer

To read the full abstract: J Sex Med. 2018 15(4)This is an important paper with a follow-up covering more than 11,000 GD patients from a single clinic in the Netherlands, looking after most (>95%) of the GD patients of the country. Long-term follow-up to adulthood of children and adolescents with GD is still lacking as the recent rapid increase of these groups has not yet resulted in sub...